Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Migraine Prophylaxis With Clopidogrel Trial
NCT02938182Phase 4Unknown
- Sponsor
- First Affiliated Hospital of Xi'an Jiaotong University
- Start
- Oct 2016
- Primary completion
- Oct 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of clopidogrel in migraine, sponsored by First Affiliated Hospital of Xi'an Jiaotong University. Primary endpoint: Change from Baseline Attack Duration of Headache at 3 months. Status: unknown.
02
Drugs
clopidogrel
03
Conditions
migraine
Beyond the preview
Go deeper on NCT02938182.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02938182.